Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.0900
-0.0500
(-1.59%)
At close: February 21 at 4:00:01 PM EST
3.0001
-0.09
(-2.91%)
After hours: February 21 at 4:45:37 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 545,600 | 13 |
| Sales | 417,575 | 2 |
| Net Shares Purchased (Sold) | 128,025 | 15 |
| Total Insider Shares Held | 8.44M | -- |
| % Net Shares Purchased (Sold) | 1.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CORCORAN ANDREA J Officer | -- | Direct | -- | Jan 31, 2025 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | -- | Direct | -- | Jan 31, 2025 |
| FOSTER WAYNE CPA Officer | -- | Direct | -- | Jan 31, 2025 |
| HORGA MARIA ARANTXA Officer | -- | Direct | -- | Jan 31, 2025 |
| HAMMOND JANET MJ Officer | -- | Direct | -- | Jan 31, 2025 |
| VAVRICKA JOHN Officer | -- | Direct | -- | Jan 31, 2025 |
| CORCORAN ANDREA J Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| FOSTER WAYNE CPA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| HORGA MARIA ARANTXA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| HAMMOND JANET MJ Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| VAVRICKA JOHN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| BERGER FRANKLIN MILAN Director | Purchase at price 3.19 - 3.36 per share. | Direct | 81,498 | Jan 16, 2025 |
| BERGER FRANKLIN MILAN Director | Sale at price 2.85 per share. | Direct | 1,023,475 | Dec 10, 2024 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | Sale at price 4.00 - 4.05 per share. | Indirect | 234,155 | Sep 19, 2024 |
| POLSKY BRUCE Director | Sale at price 3.49 per share. | Direct | 61,144 | Jun 20, 2024 |
| DUNCAN BARBARA GAYLE Director | -- | Direct | -- | Jun 14, 2024 |
| BERGER FRANKLIN MILAN Director | -- | Direct | -- | Jun 14, 2024 |
| POLSKY BRUCE Director | -- | Direct | -- | Jun 14, 2024 |
| LUCIDI BRUNO Director | -- | Direct | -- | Jun 14, 2024 |
| MURPHY POLLY A Director | -- | Direct | -- | Jun 14, 2024 |
| ADAMS JEROME M. M.D. Director | -- | Direct | -- | Jun 14, 2024 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | Sale at price 4.00 per share. | Indirect | 4,024 | Jun 5, 2024 |
| CORCORAN ANDREA J Chief Financial Officer | Sale at price 3.84 per share. | Direct | 60,915 | Feb 1, 2024 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | Sale at price 3.84 per share. | Direct | 218,819 | Feb 1, 2024 |
| FOSTER WAYNE CPA Officer | Sale at price 3.84 per share. | Direct | 47,904 | Feb 1, 2024 |
| HORGA MARIA ARANTXA Officer | Sale at price 3.84 per share. | Direct | 60,963 | Feb 1, 2024 |
| HAMMOND JANET MJ Officer | Sale at price 3.84 per share. | Direct | 53,913 | Feb 1, 2024 |
| VAVRICKA JOHN Officer | Sale at price 3.84 per share. | Direct | 45,420 | Feb 1, 2024 |
| CORCORAN ANDREA J Chief Financial Officer | -- | Direct | -- | Jan 31, 2024 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | -- | Direct | -- | Jan 31, 2024 |
| FOSTER WAYNE CPA Officer | -- | Direct | -- | Jan 31, 2024 |
| HORGA MARIA ARANTXA Officer | -- | Direct | -- | Jan 31, 2024 |
| HAMMOND JANET MJ Officer | -- | Direct | -- | Jan 31, 2024 |
| VAVRICKA JOHN Officer | -- | Direct | -- | Jan 31, 2024 |
Related Tickers
BRNS Barinthus Biotherapeutics plc
1.0000
-6.54%
CRGX CARGO Therapeutics, Inc.
3.7700
+2.17%
ACHL Achilles Therapeutics plc
1.3800
-0.72%
AADI Aadi Bioscience, Inc.
2.7900
-2.45%
SPRB Spruce Biosciences, Inc.
0.4200
-1.20%
TSBX Turnstone Biologics Corp.
0.3886
-3.36%
BOLT Bolt Biotherapeutics, Inc.
0.4880
-4.29%
IKNA Ikena Oncology, Inc.
1.3900
-4.14%
VTYX Ventyx Biosciences, Inc.
1.6100
-3.01%
ANTX AN2 Therapeutics, Inc.
1.1300
0.00%